$TTRX
Turn Therapeutics Inc. Common Stock
XNAS
Why is TTRX down today? It is at $9.21 (-2.39%), and our scanner flagged it 8 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TTRX spikes, and full due diligence on TTRX — key stats, earnings, dilution and insider activity. Free.
Get free $TTRX alerts the moment volume spikes
Our scanner flagged $TTRX 8 times in the last 30 days. Create a free account to track $TTRX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $9.21
- Change today
- -2.39%
- Previous close
- $9.43
- 52-week range
- $2.57 – $26.50
- Market cap
- $281M
- Institutional own.
- 2.78%
- Total held
- 61.6%
- Tradeable float
- 11.4M 38% of shares · after 59% insiders + 3% institutions
- Short interest
- 39K ▲ +25% vs prior · as of 2026-06-30
- Short % of float
- 0.3%
- Days to cover
- 1.0d
- Avg daily volume
- 171K
- Next earnings
- Aug 10 · in 4d
- Exchange
- XNAS
- 5mthin
- 0.0x
- 15mthin
- 0.0x
- 1hthin
- 0.0x
- 1D
- 0.0x
Get free TTRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $TTRX down today?
Here is the latest on TTRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TTRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalyst6 GX-03 for AD Phase 2 Ongoing IL-31 IL-4 IL-36, from the latest SEC filing. Read it →Insiders
Insiders buying7 open-market buys1 buys, 1 sells last 3 months (16/2 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Burnam Bradley Evan Officer | Sold (automatic/other) | -600K 2.0% of company | sold 3.8% | 15.12M | n/a | May 28, 26 |
Burnam Bradley Evan Officer | Acquired (grant/award) | +600K 2.0% of company | added 4.0% | 15.72M | n/a | May 28, 26 |
Golden Arthur F Director | Acquired (grant/award) | +300K 1.0% of company | added 100% | 361K | n/a | Apr 2, 26 |
Burnam Bradley Evan Officer | Sold (automatic/other) | -300K 1.0% of company | sold 1.9% | 15.72M | n/a | Apr 2, 26 |
Dewhurst Martin William Director | Acquired (grant/award) | +22K 0.07% of company | n/a | 22K | n/a | Jan 7, 26 |
Chaudhary Zuraiz Officer | Bought (open market) | +3K | added 25% | 13K | $9K at $3.50 | Dec 12, 25 |
Golden Arthur F Director | Bought (open market) | +10K 0.03% of company | added 19% | 61K | $34K at $3.44 | Nov 24, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +1K | added 11% | 10K | $3K at $3.29 | Nov 21, 25 |
Golden Arthur F Director | Bought (open market) | +21K 0.07% of company | added 68% | 51K | $59K at $2.87 | Nov 21, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +1K | added 19% | 9K | $4K at $2.61 | Nov 20, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +3K | added 50% | 8K | $9K at $3.62 | Nov 17, 25 |
Golden Arthur F Director | Bought (open market) | +20K 0.07% of company | added 100% | 30K | $100K at $4.95 | Oct 23, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $TTRX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$TTRX Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$TTRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
TTRX stock FAQ
Why is $TTRX down today?
Here is the latest on TTRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TTRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the TTRX stock price today?
TTRX last traded at $9.21, down 2.39% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does TTRX report earnings?
Turn Therapeutics Inc. Common Stock (TTRX) is next expected to report earnings on Monday, August 10, 2026, about 4 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live TTRX alerts?
The TTRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TTRX 8 times in the last 30 days.
What exchange is TTRX on?
TTRX (Turn Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $281M.
Is TTRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TTRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.